Stock of the Week – TG Therapeutics (TGTX)
TG Therapeutics (TGTX) is a commercial-stage biopharmaceutical firm that treats autoimmune diseases, cancers, and other B-cell diseases. The company has received approval from the FDA for Briumvi, which treats patients with relapsing forms of multiple sclerosis. The...Stock of the Week – Viking Therapeutics (VKTX)
Our Stock of the Week is Viking Therapeutics (VKTX). Viking is racing to launch an obesity drug that competes against Lilly (LLY) and Novo Nordisk (NVO). Preliminary results for its VK2735 showed excellent results with substantial weight reduction and fewer side...Stock of the Week – Lantheus Holdings, Inc. (LNTH)
Our Stock of the Week is Lantheus Holdings, Inc. (LNTH). LNTH is a radiopharmaceutical company that develops, manufactures, and sells diagnostic and therapeutic products for nuclear medicine and diagnostic imaging. Their products help healthcare professionals with...Stock of the Week – Cipher Mining, Inc. (CIFR)
Our Stock of the Week is Cipher Mining, Inc. (CIFR). CIFR describes itself as "an industrial-scale Bitcoin mining company dedicated to expanding and strengthening the Bitcoin network's critical infrastructure in the United States. Our mission is to provide...Stock of the Week – AvePoint Inc (AVPT)
Our Stock of the Week is AvePoint (AVPT). AvePoint Inc. is a Microsoft 365 data management solutions provider that offers a full suite of SaaS solutions to migrate, manage, and protect data. It sees itself as a leader in data management and data governance and has...Stock of the Week – Humacyte (HUMA)
Our Stock of the Week is Humacyte (HUMA). I’ve been discussing this stock extensively for a while, but with an FDA decision due in about a month and good support on the chart, it looks like an opportune time to evaluate the name. HUMA has developed the Acellular...Stock of the Week – Mereo BioPharma Group (MREO)
Our Stock of the Week is Mereo BioPharma Group (MREO). MREO is a UK-based biotechnology company that focuses on drugs for rare and specialty diseases. It has two key drugs in development. The first is Setrusumab, which is used for rare brittle bone disease. It has...Stock of the Week – Xeris (XERS)
Our Stock of the Week is Xeris (XERS). We have been following XERS for several years and it has been a disappointment despite its tremendous potential. We now believe that it is on the cusp of being recognized as more information is released by its in-house drug...Stock of the Week – Depegar.com (DESP)
Our Stock of the Week is Depegar.com (DESP). DESP is an Argentina-based company that provides online travel services to 2.5 million customers in Latin America. Currently, about 62% of its revenues come from hotel bookings and 37% from airlines. Its largest market is...RevShark’s New EBook
Sponsored by
